Cargando…
Report of the use of patient‐derived xenograft models in the development of anticancer drugs in Japan
Cell line‐derived xenograft (CDX) models created by implanting cancer cell lines into immunodeficient mice have contributed largely to the development of cancer drug therapies. However, cell lines often lose their original biological characteristics through many passages and cancer tissues in CDX mo...
Autores principales: | Tsumura, Ryo, Koga, Yoshikatsu, Hamada, Akinobu, Kuwata, Takeshi, Sasaki, Hiroki, Doi, Toshihiko, Aikawa, Katsuji, Ohashi, Akihiro, Katano, Ikumi, Ikarashi, Yoshinori, Ito, Mamoru, Ochiai, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469811/ https://www.ncbi.nlm.nih.gov/pubmed/32639672 http://dx.doi.org/10.1111/cas.14564 |
Ejemplares similares
-
Systematic Review of Patient-Derived Xenograft Models for Preclinical Studies of Anti-Cancer Drugs in Solid Tumors
por: Koga, Yoshikatsu, et al.
Publicado: (2019) -
ET-05 PRECLINICAL STUDY OF AN ANTI-HUMAN TISSUE FACTOR ANTIBODY-DRUG CONJUGATE IN A MALIGNANT GLIOMA XENOGRAFT MODEL
por: Takashima, Hiroki, et al.
Publicado: (2019) -
Characterization of the large‐scale Japanese patient‐derived xenograft (J‐PDX) library
por: Yagishita, Shigehiro, et al.
Publicado: (2021) -
Evaluation of the antitumor mechanism of antibody‐drug conjugates against tissue factor in stroma‐rich allograft models
por: Tsumura, Ryo, et al.
Publicado: (2019) -
Antitumor effect of antitissue factor antibody‐MMAE conjugate in human pancreatic tumor xenografts
por: Koga, Yoshikatsu, et al.
Publicado: (2015)